Nature Reviews Urology

(ISSN: 1759-4812,1759-4820)

Articles Available on Medscape

  • Where Next for The Endoscope?
    The authors trace the origins and development of endoscopic technology, from "resectoscope" to modern devices for virtual and capsule endoscopy.
 
 

Nature Reviews Urology's Latest Table of Contents

2017 -

  • Prostate cancer: Localized docetaxel delivery is feasible. 
  • Prostate cancer: A variety of therapy: ARVs mediate DDR. 
  • Concomitant bladder cancer and prostate cancer: challenges and controversies. 
  • Prostate cancer: The pathway to progression: DHT biosynthesis. 
  • Bladder cancer: The promise of liquid biopsy ctDNA analysis. 
  • Incontinence: Shockwave treatment promotes urethral smooth muscle proliferation. 
  • Prostate cancer: The influence of steroid metabolism on CYP17A1 inhibitor activity. 
  • Bladder cancer: PPARγ-RXRα alterations promote immune evasion. 
  • Cardiovascular toxicities of systemic treatments of prostate cancer: is oestrogen to the rescue? 
  • Cardiovascular toxicities of systemic treatments of prostate cancer: oestrogen to the rescue? 
  • Kidney cancer: Deciphering sarcomatoid RCC. 
  • Prostate cancer: A weighty issue: changes in chromatin regulation. 
  • Incontinence: Patients prefer combination therapy. 
  • Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials. 
  • Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough? 
  • Prostate cancer: Subtype linked to germline variant. 
  • Immunology: PD-1 and PD-L1 prognostic in UTUC. 
  • Sexuality as a health-promoting factor - theoretical and clinical considerations. 
  • Prostate cancer: Mutations in ctDNA reflect features of metastatic disease. 
  • TRACERx Renal: tracking renal cancer evolution through therapy. 
  • Prostate cancer: STAMPEDE, LATITUDE and Fernand Labrie's legacy. 
  • Science and society: Development of the Asian Men's Health Report: challenges and opportunities. 
  • Pharmacology: Cardiovascular effects of mirabegron. 
  • Kidney cancer: Savolitinib - a saviour for papillary RCC? 
  • Infection: The urinary microbiota is unique and resilient. 
  • Urinary incontinence: Stem cell therapy for chronic bladder ischaemia. 
  • Telomeres and telomerase in prostate cancer development and therapy. 
  • Landmarks in the treatment of muscle-invasive bladder cancer. 
  • Sexual dysfunction: Shortened CCH treatment for Peyronie's disease. 
  • Urothelial carcinoma: Genomic characterization of UTUC. 
  • Urinary incontinence: Evaluating bladder wall properties with vibrometry. 
  • Variation in clinical practice: forests and trees revisited. 
  • Prostate cancer: Microbiome - the 'unforeseen organ'. 
  • Bladder cancer: oligometastases and imaging. 
  • Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach. 
 
 

Mission Statement: Nature Reviews Urology commissions leaders in the field to write clinical content of the highest quality, authority and accessibility.